Short-Term and Long-Term Outcomes of Liver Cirrhosis in Gastric Neoplasm Patients Undergoing Endoscopic Submucosal Dissection
- 1 July 2023
- journal article
- research article
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 33 (7) , 640-647
Abstract
Purpose: The purpose of this study was to explore whether liver cirrhosis (LC) influences short-term and long-term outcomes in gastric neoplasm patients who undergo endoscopic submucosal dissection (ESD). Materials and Methods: Eligible studies were identified in three databases, including PubMed, Embase, and the Cochrane Library on December 18, 2022. Clinical characteristics, short-term outcomes, and long-term outcomes were compared between an LC group and a no liver cirrhosis (NLC) group. For continuous variables, the mean difference (MD) and standard deviation (SD) were pooled. For discontinuous variables, raw data from the 2 × 2 tables or odds ratio (OR) and 95% confidence intervals (CIs) were pooled. Forest plots were used to show the results, and a funnel plot was used to evaluate publication bias. Data analyses were performed by STATA SE 16.0 software. Results: Six retrospective studies involving 1616 gastric neoplasm patients were included in the study. Clinical characteristics, including age, gender, location, macroscopic type, invasion depth, differentiation, and ulceration, were found to be not significantly different between the LC group and the NLC group ( P > .05). Moreover, LC was not a risk factor for short-term outcomes, including operative time (MD = 0.15, 95% CI = −0.02 to 0.32, I 2 = 0.00%, P = .09), en bloc resection (OR = 0.87, 95% CI = 0.43–1.75, I 2 = 0.00%, P = .69), R0 resection (OR = 0.77, 95% CI = 0.42–1.43, I 2 = 8.97%, P = .41), bleeding (OR = 1.10, 95% CI = 0.62–1.93, I 2 = 0.00%, P = .75), and perforation (OR = 1.62, 95% CI = 0.45–5.84, I 2 = 0.00%, P = .46). However, gastric cancer patients with LC exhibited a higher recurrence rate (OR = 3.40, 95% CI = 1.09–10.61, I 2 = 0.00%, P = .04) after ESD. Conclusion: Surgeons performing ESD in gastric neoplasm patients should pay more attention to long-term effects.Keywords
This publication has 39 references indexed in Scilit:
- Natural killer T cells in liver injury, inflammation and cancerExpert Review of Gastroenterology & Hepatology, 2015
- Outcomes of ESD for patients with early gastric cancer and comorbid liver cirrhosis: a propensity score analysisSurgical Endoscopy, 2014
- Complications Related to Gastric Endoscopic Submucosal Dissection and Their ManagementsClinical Endoscopy, 2014
- Complications of Gastric Endoscopic Submucosal DissectionDigestive Endoscopy, 2013
- Is Laparoscopy-assisted Radical Gastrectomy Safe in Patients with Child-Pugh Class A Cirrhosis?Journal of Gastric Cancer, 2013
- The Feasibility and Safety of the Endoscopic Submucosal Dissection of Superfi cial Gastric Neoplastic Lesions in Patients with Compensated Liver Cirrhosis: A Retrospective StudyGut and Liver, 2012
- Endoscopic treatments of gastric mucosal lesions are not riskier in patients with chronic renal failure or liver cirrhosisSurgical Endoscopy, 2010
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Interpretation of tests of heterogeneity and bias in meta‐analysisJournal of Evaluation in Clinical Practice, 2008
- Measuring inconsistency in meta-analysesBMJ, 2003